Drug Trial Radar · NCT02249663
Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™
Last checked: Nov 19, 2026Latest source record: Sep 25, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
1,535
Planned (sponsor's estimate)
Start
Aug 2014
Primary completion
Feb 2015
Sponsor
- Lead sponsor
- Teva Pharmaceuticals USATeva (TEVA)
- Sponsor type
- Industry
- First posted
- Sep 25, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the therapeutic equivalence of a test formulation of Azelastine hydrochloride and Fluticasone propionate Nasal Spray to the reference listed drug, Dymista™ Nasal Spray in the relief of the signs and symptoms of Seasonal Allergic Rhinitis.
Conditions
- Seasonal Allergic Rhinitis
Interventions
Azelastine hydrochloride and Fluticasone propionateDrug
137/50 mcg Nasal Spray
Dymista™Drug
137/50 mcg Nasal Spray
PlaceboOther
Nasal spray with no pharmaceutically active content
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in average AM/PM reflective Total Nasal Symptom Score (rTNSS).Time frame: Days 1 to 14
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Novum Pharmaceutical Research Services
Pittsburgh, Pennsylvania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.